Cargando…
A balanced review of the status T cell-based therapy against cancer
A recent commentary stirred intense controversy over the status of anti-cancer immunotherapy. The commentary suggested moving beyond current anti-cancer vaccines since active-specific immunization failed to match expectations toward a more aggressive approach involving the adoptive transfer of in vi...
Autor principal: | Marincola, Francesco M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090619/ https://www.ncbi.nlm.nih.gov/pubmed/15831096 http://dx.doi.org/10.1186/1479-5876-3-16 |
Ejemplares similares
-
Letter to the editor: Checking the pulse of adoptive cell therapy for solid tumors. Thoughts from the abstracts submitted to the 35th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2020)
por: Markovska, Martina, et al.
Publicado: (2021) -
Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy
por: Wang, Ena, et al.
Publicado: (2020) -
What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014) -
Synopsis of the 6(th )Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy
por: Kast, W Martin, et al.
Publicado: (2004) -
Cancer immunotherapy trials: leading a paradigm shift in drug development
por: Emens, Leisha A., et al.
Publicado: (2016)